Weinberg Eric exercised Options for 35,168 RxSight shares at $4.34 each, resulting in ownership of 235,516 shares. The transaction represented about 14.9% of the resulting share holding and 100.0% of the prior derivative securities holding, leaving zero derivative securities after completion.
Key Highlights
- The option exercise price was $4.34 per share.
- Weinberg Eric owned 235,516 RxSight shares after the transaction.
- The exercise represented about 100.0% of the prior derivative securities holding.
The options carried an exercise price of $4.34 per share. Weinberg Eric held 235,516 RxSight (NASDAQ: RXST) shares after the transaction. The exercise involved derivative securities, and his resulting derivative securities balance was zero. The reported transaction date was Sep. 15, 2026.
Investor Insights
Measured against Weinberg Eric’s resulting share holding, the transaction represented about 14.9%. It also represented about 100.0% of his prior derivative securities holding. The resulting position therefore consisted of 235,516 shares and zero derivative securities.
FAQs
Q: What did Weinberg Eric do with RxSight options?
A: Weinberg Eric exercised options for 35,168 RxSight shares at $4.34 per share. The transaction took place on Sep. 15, 2026.
Q: How many RxSight shares did Weinberg Eric own afterward?
A: Weinberg Eric owned 235,516 RxSight shares after the option exercise. The transaction represented about 14.9% of the resulting share holding.
Q: What happened to Weinberg Eric’s derivative securities?
A: Weinberg Eric owned zero derivative securities after the transaction. The exercise represented about 100.0% of the prior derivative securities holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.